WO2001075024A3 - A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide - Google Patents
A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide Download PDFInfo
- Publication number
- WO2001075024A3 WO2001075024A3 PCT/CN2001/000368 CN0100368W WO0175024A3 WO 2001075024 A3 WO2001075024 A3 WO 2001075024A3 CN 0100368 W CN0100368 W CN 0100368W WO 0175024 A3 WO0175024 A3 WO 0175024A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- polynucleotide encoding
- human factor
- discloses
- associated human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention discloses a novel polypeptide, an NF-E2-associated human factor 13, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as malignant tumor, hemopathy, development diseases, HIV infection, immunological disease, and various inflammation, etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the NF-E2-associated human factor 13.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU56051/01A AU5605101A (en) | 2000-03-22 | 2001-03-19 | A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00115024.3 | 2000-03-22 | ||
| CN00115024A CN1314383A (en) | 2000-03-22 | 2000-03-22 | New polypeptide-human NF-E2 relation factor 13 and polynucleotide for coding such polypeptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001075024A2 WO2001075024A2 (en) | 2001-10-11 |
| WO2001075024A3 true WO2001075024A3 (en) | 2002-04-04 |
Family
ID=4584495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000368 Ceased WO2001075024A2 (en) | 2000-03-22 | 2001-03-19 | A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1314383A (en) |
| AU (1) | AU5605101A (en) |
| WO (1) | WO2001075024A2 (en) |
-
2000
- 2000-03-22 CN CN00115024A patent/CN1314383A/en active Pending
-
2001
- 2001-03-19 AU AU56051/01A patent/AU5605101A/en not_active Abandoned
- 2001-03-19 WO PCT/CN2001/000368 patent/WO2001075024A2/en not_active Ceased
Non-Patent Citations (3)
| Title |
|---|
| CHAN J.Y. ET AL.: "Chromosomal localization of the human NF-E2 family of bZIP transcription factors by fluorescence in situ hybridization", HUM. GENET., vol. 95, no. 3, 1995, pages 265 - 269 * |
| CLAVERIE J.M.: "Identifying coding exons by similarity search: alu-derived and other potentially misleading protein sequences", GENOMICS, vol. 12, no. 4, 1992, pages 838 - 841 * |
| MOI P. ET AL.: "Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region", PROC. NATL. ACAD. SCI. USA, vol. 91, no. 21, 1994, pages 9926 - 9930 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5605101A (en) | 2001-10-15 |
| CN1314383A (en) | 2001-09-26 |
| WO2001075024A2 (en) | 2001-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001088084A3 (en) | A novel polypeptide, a superoxide dismutase 11 and the polynucleotide encoding the polypeptide | |
| WO2001075036A3 (en) | A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide | |
| WO2001075024A3 (en) | A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide | |
| WO2001075016A3 (en) | A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide | |
| WO2001075011A3 (en) | A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide | |
| WO2001075058A3 (en) | A NOVEL POLYPEPTIDE, HUMAN AMINOACYL-tRNA SYNTHETASE 15 TYPE II AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE | |
| WO2001075053A3 (en) | A novel polypeptide, human chaperonine 14 and the polynucleotide encoding the polypeptide | |
| WO2001075048A3 (en) | A novel polypeptide, human ribosomal protein s11 23 and the polynucleotide encoding the polypeptide | |
| WO2002000821A3 (en) | A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide | |
| WO2002000828A3 (en) | A novel polypeptide, a zinc-finger protein 34 and the polynucleotide encoding the polypeptide | |
| WO2001083681A3 (en) | A novel polypeptide, a human dihydroorotase 21 and the polynucleotide encoding the polypeptide | |
| WO2001077287A3 (en) | A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide | |
| WO2001075062A3 (en) | A novel polypeptide, human hydrogenase 10 and the polynucleotide encoding the polypeptide | |
| WO2001075056A3 (en) | A novel polypeptide, human light-chain clathrine 20 and the polynucleotide encoding the polypeptide | |
| WO2001075039A3 (en) | A novel polypeptide, human rna helicase 10 and the polynucleotide encoding the polypeptide | |
| WO2001075007A3 (en) | A novel polypeptide, a tyrosinase 15 and the polynucleotide encoding the polypeptide | |
| WO2001075061A3 (en) | A novel polypeptide, cdv-1-42 and the polynucleotide encoding the polypeptide | |
| WO2001079431A3 (en) | A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide | |
| WO2001075034A3 (en) | A novel polypeptide, human peroxydase protein 15 and the polynucleotide encoding the polypeptide | |
| WO2001075035A3 (en) | A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide | |
| WO2001075023A3 (en) | A novel polypeptide, human phosphatidylinositol-3 (ptdins 3) kinase 9 and the polynucleotide encoding the polypeptide | |
| WO2001075057A3 (en) | A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide | |
| WO2001075043A3 (en) | A novel polypeptide, dna-dependent human protein kinase 9 and the polynucleotide encoding the polypeptide | |
| WO2001083682A3 (en) | A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide | |
| WO2001075018A3 (en) | A novel polypeptide, a human regulation factor of transcription 31 and the polynucleotide encoding the polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |